Soligenix, Inc. (SNGX)
0.3681
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
0.3681
0.00 (0.00%)
After-Hours: 20:00
Soligenix Enterprise Value : -1.568M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | -1.568M |
| September 08, 2026 | -1.332M |
| September 04, 2026 | -1.286M |
| September 03, 2026 | -1.217M |
| September 02, 2026 | -1.250M |
| September 01, 2026 | -1.373M |
| August 31, 2026 | -1.286M |
| August 28, 2026 | -1.356M |
| August 27, 2026 | -1.286M |
| August 26, 2026 | -1.200M |
| August 25, 2026 | -0.7431M |
| August 24, 2026 | -0.7518M |
| August 21, 2026 | -0.8319M |
| August 20, 2026 | -1.284M |
| August 19, 2026 | -1.262M |
| August 18, 2026 | -0.94M |
| August 17, 2026 | -1.260M |
| August 14, 2026 | -0.8535M |
| August 13, 2026 | -1.267M |
| August 12, 2026 | -1.070M |
| August 11, 2026 | -1.146M |
| August 10, 2026 | -1.340M |
| August 07, 2026 | -1.024M |
| August 06, 2026 | -1.312M |
| August 05, 2026 | -1.224M |
| Date | Value |
|---|---|
| August 04, 2026 | -1.351M |
| August 03, 2026 | -1.340M |
| July 31, 2026 | -1.418M |
| July 30, 2026 | -1.394M |
| July 29, 2026 | -1.684M |
| July 28, 2026 | -1.684M |
| July 27, 2026 | -1.678M |
| July 24, 2026 | -1.474M |
| July 23, 2026 | -1.535M |
| July 22, 2026 | -1.665M |
| July 21, 2026 | -1.630M |
| July 20, 2026 | -1.754M |
| July 17, 2026 | -1.741M |
| July 16, 2026 | -1.726M |
| July 15, 2026 | -1.459M |
| July 14, 2026 | -1.505M |
| July 13, 2026 | -1.875M |
| July 10, 2026 | -1.721M |
| July 09, 2026 | -1.548M |
| July 08, 2026 | -1.503M |
| July 07, 2026 | -1.161M |
| July 06, 2026 | -1.182M |
| July 02, 2026 | -1.135M |
| July 01, 2026 | -0.9184M |
| June 30, 2026 | -0.94M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.882B |
| Alnylam Pharmaceuticals, Inc. | 34.18B |
| Anika Therapeutics, Inc. | 266.28M |
| Savara, Inc. | 969.61M |
| Vericel Corp. | 1.927B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.987M |
| Total Expenses (Quarterly) | 1.987M |
| EPS Diluted (Quarterly) | -0.1246 |
| Earnings Yield | -346.2% |
| Normalized Earnings Yield | -346.86 |